HSP90AA1 and cystic fibrosis: On the other hand, Aha1 was found to enhance the misfolding of cystic fibrosis transmembrane conductance regulator and the disease-relevant Δ508 mutant found in cystic fibrosis patients by diminishing the dwell time of these difficult-to-fold client proteins on HSP90 (17).